FA
ABBV icon

Fiducient Advisors’s AbbVie ABBV Stock Holding History

Fiducient Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$910K Buy
3,615
+24
+0.7% +$5.16K 0.13% 82
2026
Q1 		$781K Sell
3,591
-1,265
-26% -$281K 0.1% 82
2025
Q4 		$1.11M Buy
4,856
+42
+0.9% +$9.57K 0.14% 82
2025
Q3 		$1.11M Buy
4,814
+349
+8% +$71.1K 0.13% 78
2025
Q2 		$829K Sell
4,465
-991
-18% -$184K 0.1% 83
2025
Q1 		$1.14M Buy
5,456
+2,037
+60% +$396K 0.14% 72
2024
Q4 		$608K Sell
3,419
-1,095
-24% -$201K 0.08% 91
2024
Q3 		$892K Buy
4,514
+69
+2% +$12.9K 0.1% 76
2024
Q2 		$762K Sell
4,445
-3,415
-43% -$566K 0.11% 76
2024
Q1 		$1.43M Buy
7,860
+1,456
+23% +$251K 0.28% 36
2023
Q4 		$992K Buy
6,404
+1,160
+22% +$169K 0.19% 43
2023
Q3 		$782K Buy
+5,244
New +$770K 0.04% 57
2023
Q1 		– Sell
-1,980
Closed -$320K – 50
2022
Q4 		$320K Buy
1,980
+47
+2% +$7.21K 0.09% 133
2022
Q3 		$259K Hold
1,933
– – 0.12% 48
2022
Q2 		$296K Sell
1,933
-116
-6% -$17.7K 0.11% 69
2022
Q1 		$332K Buy
2,049
+155
+8% +$22.5K 0.13% 48
2021
Q4 		$256K Sell
1,894
-3,007
-61% -$355K 0.08% 51
2021
Q3 		$529K Sell
4,901
-200
-4% -$22.9K 0.16% 50
2021
Q2 		$575K Sell
5,101
-140
-3% -$15.8K 0.18% 36
2021
Q1 		$567K Buy
5,241
+140
+3% +$15K 0.18% 39
2020
Q4 		$547K Buy
+5,101
New +$490K 0.2% 37

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fiducient Advisors's ABBV Position: Q2 2026 in Review

Fiducient Advisors increased its AbbVie (ABBV) stake by 0.67% in Q2 2026, buying an estimated $5.16K and bringing the position to 3,615 shares worth $910K. The position accounts for 0.13% of the portfolio, ranked #82.

Fiducient Advisors first reported a position in ABBV in Q4 2020 and has held it in 21 quarters since. The position peaked at $1.43M in Q1 2024. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Fiducient Advisors held 3,615 shares of AbbVie worth $910K as of Q2 2026.
  • Fiducient Advisors bought 24 AbbVie shares in Q2 2026, an estimated $5.16K.
  • AbbVie made up 0.13% of Fiducient Advisors's portfolio in Q2 2026, its #82 holding.
  • Fiducient Advisors first reported a position in AbbVie in Q4 2020 and has held it in 21 quarters since.
  • Fiducient Advisors's AbbVie position peaked at $1.43M in Q1 2024.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Fiducient Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.